• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Video

Clinical Experiences of Using Circulating Tumor DNA

Author(s):

Mary Scoviak, Managing Editor
Conference|American Academy of Dermatology

In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).

Related Videos
Related Content
Neoadjuvant Intralesional 5-Fluorouracil Injection: Improved SCC Treatment in Older Patients
October 14th 2024

Neoadjuvant Intralesional 5-Fluorouracil Injection: Improved SCC Treatment in Older Patients

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Q&A: Jeffrey Stricker, DO, MBA, Discusses Study on Image-Guided SRT in Non-Melanoma Skin Cancers
September 4th 2024

Q&A: Jeffrey Stricker, DO, MBA, Discusses Study on Image-Guided SRT in Non-Melanoma Skin Cancers

The Cutaneous Connection: Episode 27
July 22nd 2021

The Cutaneous Connection: Episode 27- Benzene Contamination Update

Q&A: DaRT Guidelines for Nonmelanoma Skin Cancer Care
August 2nd 2024

Q&A: DaRT Guidelines for Nonmelanoma Skin Cancer Care

Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
July 24th 2024

Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised

© 2024 MJH Life Sciences

All rights reserved.